“Piboserod”的意思、由来-开放百科全书

词条

Piboserod

释义

Mechanism of action
References

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 408035930
| IUPAC_name = N-((1-Butyl-4-piperidyl)-methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide
| image = Piboserod.png
| tradename =
| legal_status = Clinical phase II
| routes_of_administration = Oral
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 152811-62-6
| ATC_prefix = none
| PubChem = 177336
| IUPHAR_ligand = 225
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 4UQ3S81B25
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 356359
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 154413
| C=22 | H=31 | N=3 | O=2
| molecular_weight = 369.50 g/mol
| smiles = CCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C22H31N3O2/c1-2-3-11-24-13-9-17(10-14-24)16-23-21(26)20-18-7-4-5-8-19(18)25-12-6-15-27-22(20)25/h4-5,7-8,17H,2-3,6,9-16H2,1H3,(H,23,26)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = KVCSJPATKXABRQ-UHFFFAOYSA-N
}}

Piboserod is a selective 5-HT₄ receptor antagonist which was marketed and manufactured by GlaxoSmithKline (GSK) under the trade name Serlipet for the management of atrial fibrillation and irritable bowel syndrome. In 2007 the Norwegian company Bio-Medisinsk Innovasjon AS (BMI)^[1] completed a clinical phase II study to investigate the effect of piboserod in patients with chronic heart failure.

Mechanism of action

In 2002 a research group at the University of Oslo discovered that muscles from the ventricle of failing hearts have increased responsiveness to serotonin.^[2] They later demonstrated that the effect was due to an expression of functional 5-HT₄ receptors in the failing muscle. On the basis of these findings, and in analogy with the success of betablockers in heart failure, the group made the hypothesis that 5-HT₄ receptor antagonists could be useful to treat heart failure. Their hypothesis was tested in animal models of heart failure with positive results.^[3]

References

1. ^Company web-page
2. ^{{cite journal | last1 = Bratteli | first1 = T. | display-authors = etal | year = 2004 | title = Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure. Naunyn-Schmiedeberg's | url = | journal = Naunyn-Schmiedeberg's Archives of Pharmacology| volume = 370 | issue = 3| pages = 157–166 | doi=10.1007/s00210-004-0963-0| pmid = 15365689 }}
3. ^{{cite journal | last1 = Birkeland | first1 = JA. | display-authors = etal | date = Jan 2007 | title = Effects of treatment with a 5-HT4 receptor antagonist in heart failure | url = | journal = British Journal of Pharmacology| volume = 150 | issue = 2| pages = 143–52 | doi=10.1038/sj.bjp.0706966| pmid = 17160012 | pmc = 2042907}}

5 : 5-HT4 antagonists|Piperidines|Carboxamides|Indoles|GlaxoSmithKline brands

随便看

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。